In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A6267

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global In-vivo CRO Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Rodent
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Rats
           6.1.2.2 Mice
           6.1.2.3 Others
        6.1.3 Market Forecast
    6.2    Non-Rodent
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by GLP Type
    7.1    Non-GLP
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 In House
           7.1.2.2 Outsourcing
        7.1.3 Market Forecast
    7.2    GLP Toxicology
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 In House
           7.2.2.2 Outsourcing
        7.2.3 Market Forecast
8   Market Breakup by Indication
    8.1    Autoimmune/Inflammation Conditions
        8.1.1 Market Trends
        8.1.2 Key Segments
           8.1.2.1 Rheumatoid Arthritis
           8.1.2.2 Multiple Sclerosis
           8.1.2.3 Osteoarthritis
           8.1.2.4 Irritable Bowel Syndrome
           8.1.2.5 Others
        8.1.3 Market Forecast
    8.2    Pain Management
        8.2.1 Market Trends
        8.2.2 Key Segments
           8.2.2.1 Chronic Pain
           8.2.2.2 Acute Pain
        8.2.3 Market Forecast
    8.3    Oncology
        8.3.1 Market Trends
        8.3.2 Key Segments
           8.3.2.1 Blood Cancer
           8.3.2.2 Solid Tumor
           8.3.2.3 Others
        8.3.3 Market Forecast
    8.4    CNS Conditions
        8.4.1 Market Trends
        8.4.2 Key Segments
           8.4.2.1 Epilepsy
           8.4.2.2 Parkinson’s Disease
           8.4.2.3 Huntington’s Disease
           8.4.2.4 Stroke
           8.4.2.5 Traumatic Brain Injury
           8.4.2.6 ALS
           8.4.2.7 Muscle Regeneration
           8.4.2.8 Others
        8.4.3 Market Forecast
    8.5    Diabetes
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Obesity
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Charles River Laboratories International Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Evotec SE
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    ICON plc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Iris Pharma (ABIONYX Pharma)
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Labcorp Drug Development (Laboratory Corporation of America Holdings)
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 SWOT Analysis
        14.3.6    North American Science Associates LLC
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Parexel International Corporation
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 SWOT Analysis
        14.3.8    Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Pronexus Analytical AB
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    Syneos Health
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    WuXi AppTec
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2024
Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2024
Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2024
Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2024
Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: North America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: United States: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: China: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: India: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: France: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Others: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2024
Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million USD), 2025-2033
Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: In-vivo CRO Market: Competitive Structure
Table 7: Global: In-vivo CRO Market: Key Players

In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials